AI-EXPO
6.6.2018 18:27:09 CEST | Business Wire | Press release
Arriving in Amsterdam on the 27-28 June , the second annual AI Expo Europe event will host 2 co-located events covering IoT and Blockchain , with 8,000 attendees expected to attend including CTO’s, CDO’s, Head’s of Innovation and Technology, IT Directors, Developers & Start-Up’s, OEM’s, Government, Automotive, Operators, Technology Providers, Investors, VCs and many more. The AI Expo will showcase the most cutting-edge technologies from more than 300 exhibitors and provide insight from over 300 speakers sharing their unparalleled industry knowledge and real-life experiences.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180606006061/en/
1. The exhibition and start-up incubator zone
The event will host a dedicated start-up incubator zone where you can see the latest AI & IoT technologies and innovations in action, in addition to the vast exhibition of 300+ companies who will be showcasing their products and services within the field of AI, IoT & Blockchain. Expect to see demos and booths from Microsoft, IBM, PTC, Kore, Hercules, Thales, Rutronik, Enterprise Ethereum Alliance, BPU Holdings, Start-up Amsterdam, ML6, Bottos, Ortec Data Science, Adani, NTR Labs, Prosper BI and many more. Start-ups within the incubator zone include Aiir Innovations, Botsquad, Mercury.AI, IoTify, Porter, 3D Universium, Zazu, 904 Labs, Innovation in Motion, Blockhearts, Mind Trace, Sightcorp, Cupenya, Effect.Ai, Sodaq, Amberscript, BrainCreators, Clockworks to name a few. In addition, attendees can join speakers from Aiir Innovations, Mercury.AI and BrainCreators within the AI Technologies track on day 2 (28th June) as they explore innovative artificial intelligence techniques.
2. 10 Conference Tracks covering AI, IoT and Blockchain
Your Free Expo Pass will provide access to 10 conference tracks; AI Technologies , Data Analytics for AI & IoT, Developing for the IoT , Privacy & Security , IoT Innovations & Technologies , ICOs & Token Investments, Blockchain for Business , Developing Blockchain Applications , Blockchain Technologies and Blockchain Strategies. Register for your free expo pass here.
3. Keynote Panel: IoT and AI data analytics for intelligent decision making
Taking place on the 27th June at 10.15am within the Data Analytics for AI & IoT conference track, the Chief Data Scientist at Southern Water , a Data Scientist from Monsanto, a Data Scientist from Marel Poulty and the CEO from the predictive intelligence firm Prosper BI will be identifying target-rich, high-value data that can be used to generate business intelligence, looking at the use of cloud analytics platforms to derive value from AI & IoT data, and discussing the barriers to widespread AI/IoT/Big Data value delivery and how these might be overcome.
4. Machine Learning and AI: Do’s and Don’ts in the online food provider industry
Adrian Foltyn, Former Head/Director of Data Science at HelloFresh, the online food survival kit provider, will take to the stage within the Data & Analytics for AI & IoT track on the 27 June at 15.20pm. Adrian will discuss why preference data is at the core of the company’s operations as their predictive technologies forecast the food that their consumers want during certain seasons.
5. AI and Computer Vision – Intelligent Assistants and an extra pair of eyes…
Join Miriam Huijser, Co-Founder & Chief Research Officer at Aiir Innovations on 28 June within the AI Technologies conference track as she explores how intelligence assistants can be used to inspect aircraft engines using state-of-the-art computer vision techniques. Aiir Innovations is an Amsterdam based start-up that aims to bring artificial intelligence to the maintenance and aircraft industry. They will also be exhibiting within the start-up incubator zone within the expo floor.
6. 2 co-located events
Co-located with the IoT Tech Expo and the Blockchain Expo, the AI Exhibition and Conference will allow you to explore 3 ecosystems in 1 and discover how the convergence of these 3 areas is powering the future of technology!
7. Using Big Data to create intelligent data models
Within the dedicated Data Analytics for AI & IoT track on the 27 June at 14.40pm, join AI & IoT thought leaders as they take to the stage for a panel discussion. Hear from Christophe Eschenbrenner, IoT & Data Foundations Program Manager from Alstom Digital Mobility , Violeta Misheva, Data Scientist at ABN AMRO Bank N.V. , Filippo F.G. Della Casa, Head of Analytics at Unipol and Dor Kedem, Senior Data Scientist at ING as they discuss the increased need for big data analytics to drive AI & Machine Learning across a range of industries.
Other event features include exclusive networking opportunities
Following the first day of the event, Speakers, Sponsors, Press, Ultimate, Gold and Expo Plus attendees are invited to attend an evening of networking.
The Beach House will host the official networking party. It is located at the entrance of The Beach and surrounded by stunning beach scenery. Set away from the busier main structures and with its own bar and terrace. Discuss the topics from the conferences and build relationships with like-minded companies and individuals.
To register for your networking (Ultimate/ Gold/ Expo Plus) pass, click here.
The final advance rate ends 15 June so if you are looking for full conference and networking access, you can save up to €150 on your conference and networking pass (Gold/Ultimate) when you book by then.
You can find out more about the World Series 2018 and register for each event here:
AI Expo Europe – 27-28 th June 2018, RAI, Amsterdam
AI Expo North America – 28-29 th November 2018, Santa Clara, Silicon Valley
AI Expo Global – 25-26 th April 2019 , Olympia Grand, London
View source version on businesswire.com: https://www.businesswire.com/news/home/20180606006061/en/
Contact:
Anna Fry
Marketing Executive | AI Expo
anna@ai-expo.net
www.ai-expo.net/
+44
(0) 117 980 9020
Link:
Social Media:
https://www.facebook.com/aiexpoworldseries/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom